Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis-Reference-Cited by-同舟云学术

Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis

Published:2020-08-07 Issue:5 Volume:35 Page:488-492
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Shibuya Tomoyoshi¹^ORCID,Haga Keiichi¹,Saeki Michio¹,Haraikawa Mayuko¹,Tsuchihashi Hitoshi²,Okahara Koki¹,Nomura Osamu¹^ORCID,Fukushima Hirofumi¹,Murakami Takashi¹,Ishikawa Dai¹,Ikeda Shigaku²,Nagahara Akihito¹

Affiliation:

1. Department of Gastroenterology Juntendo University School of Medicine Tokyo Japan

2. Department of Dermatology Juntendo University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21821

Reference23 articles.

1. Biological therapy for dermatological manifestations of inflammatory bowel disease

2. Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease